Welcome to our dedicated page for FMC Corporation news (Ticker: $FMC), a resource for investors and traders seeking the latest updates and insights on FMC Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FMC Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FMC Corporation's position in the market.
Amyris, Inc. has appointed Kathy L. Fortmann as its new CEO, bringing 35 years of global business experience. Ms. Fortmann replaces Han Kieftenbeld and aims to lead the company through innovation and growth. With a background in specialty chemicals and ingredients, she is excited to work with the Board and colleagues to execute Amyris' strategy.
FMC reported first quarter 2024 earnings at the higher end of the guidance range. Revenue was $918 million, down 32% from Q1 2023. Adjusted EBITDA was $161 million, down 56% from Q1 2023. The company maintains full-year outlook with revenue expected to be $4.50 to $4.70 billion and adjusted EBITDA outlook of $900 million to $1.05 billion. Free cash flow outlook remains at $400 million to $600 million.
FMC (NYSE: FMC) declared a regular quarterly dividend of 58 cents per share, payable on July 18, 2024, to shareholders of record as of June 28, 2024.